(Q37949849)

25 August 2017

title

The NSAID dilemma: managing osteoarthritis in high-risk patients (English)

1 reference

25 August 2017

0 references

Sanford H Roth

1

1 reference

25 August 2017

Shane Anderson

series ordinal

2

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 September 2011

1 reference

The Physician and Sportsmedicine

25 August 2017

published in

1 reference

25 August 2017

volume

39

1 reference

25 August 2017

issue

3

1 reference

25 August 2017

page(s)

62-74

1 reference

Nonsteroidal anti-inflammatory drugs: gastropathy, deaths, and medical practice

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Comparison of general practitioners and rheumatologists' prescription patterns for patients with knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Prescription patterns and appropriateness of NSAID therapy according to gastrointestinal risk and cardiovascular history in patients with diagnoses of osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Understanding the COX-2/NSAID dilemma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

The discovery of aspirin: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Renal adverse effects of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Risks versus benefits of cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Ag

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Preventing the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: from risk factor identification to risk factor intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Prospects for changing the burden of nonsteroidal anti-inflammatory drug toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

A model analysis of costs of blood pressure destabilization and edema associated with rofecoxib and celecoxib among older patients with osteoarthritis and hypertension in a medicare choice population

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III).

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Drug-drug interactions in a geriatric outpatient cohort: prevalence and relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

High concomitant use of interacting drugs and low use of gastroprotective drugs among NSAID users in an unselected elderly population: a nationwide register-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Celecoxib for the prevention of colorectal adenomatous polyps

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Celecoxib for the prevention of sporadic colorectal adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Misoprostol therapeutics revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Guidelines for prevention of NSAID-related ulcer complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Long-term proton pump inhibitor therapy and risk of hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

NSAID-induced gastrointestinal and cardiovascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

21 January 2018

Adherence to Medication

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Update on the use of topical NSAIDs for the treatment of soft tissue and musculoskeletal pain: a review of recent data and current treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Topical preparations for pain relief: efficacy and patient adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

In vivo bioavailability and metabolism of topical diclofenac lotion in human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Adverse effects of topical nonsteroidal antiinflammatory drugs in older adults with osteoarthritis: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

The FDA Acetaminophen Advisory Committee Meeting - what is the future of acetaminophen in the United States? The perspective of a committee member

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

A new role for opioids in the treatment of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

The comparative safety of analgesics in older adults with arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

The comparative safety of opioids for nonmalignant pain in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled pha

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

30-Day Mortality After Peptic Ulcer Perforation Among Users of Newer Selective Cox-2 Inhibitors and Traditional NSAIDs: A Population-Based Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

Intra‐articular sodium hyaluronate 2 mL versus physiological saline 20 mL versus physiological saline 2 mL for painful knee osteoarthritis: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2011.09.1922

21 January 2018

Identifiers

DOI

10.3810/PSM.2011.09.1922

1 reference

25 August 2017

1 reference